Fla. based Tyndall Federal Credit Union, an FI with $1 billion in assets, has expanded its relationship with Diebold Inc. (NYSE:DBD) in order to increase convenience for its members while heightening the security of its ATM fleet, according to a Diebold news release. On last trading day Diebold Inc. (NYSE:DBD) ended up 0.18%higher to close at $40.06 while trading in the range of $39.78 – $40.59. Its return on assets (ROA) is -7.50% while return on investment (ROI) is -15.60%.Diebold Inc. (NYSE:DBD) monthly performance is 10.85%.

Genworth Financial Inc. (NYSE:GNW) CEO Thomas J. McInerney to Discuss the Future of the U.S. Long Term Care Insurance Market at ILTCI Conference. Genworth Financial Inc. (NYSE:GNW) in last trading activity ended up at $17.56 with day range of $17.09 – $17.67. Company weekly performance is 4.52% while its quarterly performance stands at 16.76%.Genworth Financial Inc. (NYSE:GNW) is 2.21% away from its 52 week high.

Equities researchers at Maxim Group hoisted their target price on shares of Synthetic Biologics (NYSE:SYN) from $3.00 to $6.00 in a research report issued on Wednesday, American Banking and Market News reports. The firm currently has a “buy” rating on the stock. Maxim Group’s target price indicates a potential upside of 95.43% from the stock’s previous close. Synthetic Biologics Inc. (NYSEMKT:SYN) belongs to Healthcare sector with market capitalization of 154.06 million and has 16.72% insider ownership. In last trading activity company’s stock closed at $3.45 while opening price was $3.33.

UnitedHealth Group (NYSE:UNH) Director William C. Ballard, Jr. unloaded 10,000 shares of the stock in a transaction dated Tuesday, March 18th. The stock was sold at an average price of $77.87, for a total transaction of $778,700.00. Following the sale, the director now directly owns 65,042 shares in the company, valued at approximately $5,064,821. On Wednesday shares of UnitedHealth Group Inc. (NYSE:UNH) opened at $78.07 and closed at $79.96. This year Company’s Earnings per Share (EPS) growth is 5.50 and next year’s estimated EPS growth is 9.19%. Analysts mean target price for UnitedHealth Group Inc. (NYSE:UNH) is $82.68.